CLASS I ONGOING Drug recall · Reported 11 Mar 2026 · FDA Enforcement Report
Silintan 25/pills recalled by ANTHONY TRINH, 123Herbals
ANTHONY TRINH, 123Herbals is recalling Silintan 25/pills, distributed nationwide in the US. The recall was initiated on 20 Oct 2025 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0388-2026
- FDA event ID
- 98258
- Recalling firm
- ANTHONY TRINH, 123Herbals, Rosemead, CA
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- 20 Oct 2025
- FDA classified
- 13 Mar 2026
- Reported
- 11 Mar 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Labeling Errors
Timeline
| 20 Oct 2025 | Recall initiated by company | |
| 11 Mar 2026 | Published in enforcement report | +142 days |
| 13 Mar 2026 | Classified by FDA | +2 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Product as listed by the FDA
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Where it was distributed
USA nationwide
Questions about this recall
Is Silintan 25/pills recalled?
Yes. ANTHONY TRINH, 123Herbals recalled Silintan 25/pills on 20 Oct 2025. The recall is Class I and its status is Ongoing. Recall number D-0388-2026.
Why was it recalled?
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Which lots are affected?
All lots within expiry
Where was it sold?
USA nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.